Targeting mitochondria as a therapeutic anti-gastric cancer approach
- 28 January 2022
- journal article
- review article
- Published by Springer Nature in Apoptosis
- Vol. 27 (3-4) , 163-183
Abstract
Gastric cancer is regarded as the fifth most common cancer globally but the third most common cancer death. Although systemic chemotherapy is the primary treatment for advanced gastric cancer patients, the outcome of chemotherapy is unsatisfactory. Novel therapeutic strategies and potential alternative treatments are therefore needed to overcome the impact of this disease. At a cellular level, mitochondria play an important role in cell survival and apoptosis. A growing body of studies have shown that mitochondria play a central role in the regulation of cellular function, metabolism, and cell death during carcinogenesis. Interestingly, the impact of mitochondrial dynamics, including fission/fusion and mitophagy, on carcinogenesis and cancer progression has also been reported, suggesting the potential targeting of mitochondrial dynamics for the treatment of cancer. This review not only comprehensively summarizes the homeostasis of gastric cancer cells, but the potential therapeutic interventions for the targeting of mitochondria for gastric cancer therapy are also highlighted and discussed.Keywords
Funding Information
- The Senior Research Scholar grant from the National Research Council of Thailand
- Thailand Science Research and Innovation-Chiang Mai University
- The NSTDA Research Chair grant from the National Science and Technology Development Agency Thailand
- The National Research Council of Thailand (2563NRCT321511)
- The Chiang Mai University Center of Excellence Award
This publication has 79 references indexed in Scilit:
- Effect and Mechanism of Mitomycin C Combined with Recombinant Adeno-Associated Virus Type II against GliomaInternational Journal of Molecular Sciences, 2013
- Anti-Tumor Effects of Mfn2 in Gastric CancerInternational Journal of Molecular Sciences, 2013
- Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancersJournal of Hematology & Oncology, 2013
- Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatinGastric Cancer, 2009
- A phase II study of intra-arterial chemotherapy of 5-fluorouracil, cisplatin, and mitomycin C for advanced nonresectable gastric cancerAnti-Cancer Drugs, 2009
- Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancerAnti-Cancer Drugs, 2009
- Effect of asymmetric distribution of phospholipids in ghost membrane from rat blood on peroxidation induced by ferrous ionFEBS Letters, 2005
- Human gastric signet ring carcinoma (KATO-III) cell apoptosis induced by Vitex agnus-castus fruit extract through intracellular oxidative stressThe International Journal of Biochemistry & Cell Biology, 2005
- Cell death induced by Pteris semipinnata L. is associated with p53 and oxidant stress in gastric cancer cellsFEBS Letters, 2005
- Growth inhibition and apoptosis of gastric cancer cell lines by Anemarrhena asphodeloides BungeJournal of Gastroenterology, 2001